{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:20:06Z","timestamp":1790400006423,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T00:00:00Z","timestamp":1732406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T00:00:00Z","timestamp":1732406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["EXC 2145 SyNergy \u2013 ID 390857198"],"award-info":[{"award-number":["EXC 2145 SyNergy \u2013 ID 390857198"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Klinikum der Universit\u00e4t M\u00fcnchen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Tau PET has attracted increasing interest as an imaging biomarker for 4-repeat (4R)-tauopathy progressive supranuclear palsy (PSP). However, the translation of in vitro 4R-tau binding to in vivo tau PET signals is still unclear. Therefore, we performed a translational study using a broad spectrum of advanced methodologies to investigate the sources of [<jats:sup>18<\/jats:sup>F]PI-2620 tau PET signals in individuals with 4R-tauopathies, including a pilot PET autopsy study in patients. First, we conducted a longitudinal [<jats:sup>18<\/jats:sup>F]PI-2620 PET\/MRI study in a 4-repeat-tau mouse model (PS19) and detected elevated [<jats:sup>18<\/jats:sup>F]PI-2620 PET signals in the presence of high levels of neuronal tau. An innovative approach involving cell sorting after radiotracer injection in vivo revealed higher tracer uptake in single neurons than in the astrocytes of PS19 mice. Regional [<jats:sup>18<\/jats:sup>F]PI-2620 tau PET signals during the lifetime correlated with the abundance of fibrillary tau and with autoradiography signal intensity in PSP patients and disease controls who underwent autopsy 2\u201363\u00a0months after tau PET. In autoradiography, tau-positive neurons and oligodendrocytes with a high AT8 density, but not tau-positive astrocytes, were the drivers of [<jats:sup>18<\/jats:sup>F]PI-2620 autoradiography signals in individuals with PSP. The high tau abundance in oligodendrocytes at the boundary of gray and white matter facilitated the identification of an optimized frontal lobe target region to detect the tau burden in patients with PSP. In summary, neuronal and oligodendroglial tau constitutes the dominant source of tau PET radiotracer binding in 4-repeat-tauopathies, translating to an in vivo signal.<\/jats:p>","DOI":"10.1007\/s00401-024-02834-7","type":"journal-article","created":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T08:44:45Z","timestamp":1732437885000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Neuronal and oligodendroglial, but not astroglial, tau translates to in vivo tau PET signals in individuals with primary tauopathies"],"prefix":"10.1007","volume":"148","author":[{"given":"Luna","family":"Slemann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Gn\u00f6rich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selina","family":"Hummel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"Bartos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Klaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes","family":"Kling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Kusche-Palenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian T.","family":"Kunte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea H.","family":"Kunze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelie L.","family":"Englert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letizia","family":"Vogler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Katzdobler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Palleis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Bernhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"J\u00e4ck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Zwergal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Hopfner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian N.","family":"Roemer-Cassiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Biechele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"St\u00f6cklein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Bischof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thilo","family":"van Eimeren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Drzezga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama","family":"Sabri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henryk","family":"Barthel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gesine","family":"Respondek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Grimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Herms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Paeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Willroider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonie","family":"Beyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnter U.","family":"H\u00f6glinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrun","family":"Roeber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolai","family":"Franzmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9247-2843","authenticated-orcid":false,"given":"Matthias","family":"Brendel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,24]]},"reference":[{"key":"2834_CR1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00401-023-02672-z","volume":"147","author":"C Aguero","year":"2024","unstructured":"Aguero C, Dhaynaut M, Amaral AC, Moon SH, Neelamegam R, Scapellato M et al (2024) Head-to-head comparison of [18F]-Flortaucipir, [18F]-MK-6240 and [18F]-PI-2620 postmortem binding across the spectrum of neurodegenerative diseases. Acta Neuropathol 147:25. https:\/\/doi.org\/10.1007\/s00401-023-02672-z","journal-title":"Acta Neuropathol"},{"key":"2834_CR2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40478-019-0686-6","volume":"7","author":"C Aguero","year":"2019","unstructured":"Aguero C, Dhaynaut M, Normandin MD, Amaral AC, Guehl NJ, Neelamegam R et al (2019) Autoradiography validation of novel tau PET tracer [F-18]-MK-6240 on human postmortem brain tissue. Acta Neuropathol Commun 7:37. https:\/\/doi.org\/10.1186\/s40478-019-0686-6","journal-title":"Acta Neuropathol Commun"},{"key":"2834_CR3","doi-asserted-by":"publisher","first-page":"9340","DOI":"10.1523\/JNEUROSCI.22-21-09340.2002","volume":"22","author":"B Allen","year":"2002","unstructured":"Allen B, Ingram E, Takao M, Smith MJ, Jakes R, Virdee K et al (2002) Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein. J Neurosci 22:9340\u20139351","journal-title":"J Neurosci"},{"key":"2834_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0283941","volume":"18","author":"IS Amorim","year":"2023","unstructured":"Amorim IS, Challal S, Cistarelli L, Dorval T, Abjean L, Touzard M et al (2023) A seeding-based neuronal model of tau aggregation for use in drug discovery. PLoS ONE 18:e0283941. https:\/\/doi.org\/10.1371\/journal.pone.0283941","journal-title":"PLoS ONE"},{"key":"2834_CR5","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00401-020-02255-2","volume":"141","author":"J Attems","year":"2021","unstructured":"Attems J, Toledo JB, Walker L, Gelpi E, Gentleman S, Halliday G et al (2021) Neuropathological consensus criteria for the evaluation of Lewy pathology in post-mortem brains: a multi-centre study. Acta Neuropathol 141:159\u2013172. https:\/\/doi.org\/10.1007\/s00401-020-02255-2","journal-title":"Acta Neuropathol"},{"key":"2834_CR6","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12974-023-02749-2","volume":"20","author":"A Ballweg","year":"2023","unstructured":"Ballweg A, Klaus C, Vogler L, Katzdobler S, Wind K, Zatcepin A et al (2023) [18F]F-DED PET imaging of reactive astrogliosis in neurodegenerative diseases: preclinical proof of concept and first-in-human data. J Neuroinflammation 20:68. https:\/\/doi.org\/10.1186\/s12974-023-02749-2","journal-title":"J Neuroinflammation"},{"key":"2834_CR7","doi-asserted-by":"publisher","first-page":"8986","DOI":"10.1126\/sciadv.adi8986","volume":"9","author":"LM Bartos","year":"2023","unstructured":"Bartos LM, Kirchleitner SV, Kolabas ZI, Quach S, Beck A, Lorenz J et al (2023) Deciphering sources of PET signals in the tumor microenvironment of glioblastoma at cellular resolution. Sci Adv 9:8986. https:\/\/doi.org\/10.1126\/sciadv.adi8986","journal-title":"Sci Adv"},{"key":"2834_CR8","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.2967\/jnumed.122.264171","volume":"63","author":"LM Bartos","year":"2022","unstructured":"Bartos LM, Kunte ST, Beumers P, Xiang X, Wind K, Ziegler S et al (2022) Single-cell radiotracer allocation via immunomagnetic sorting to disentangle PET signals at cellular resolution. J Nucl Med 63:1459\u20131462. https:\/\/doi.org\/10.2967\/jnumed.122.264171","journal-title":"J Nucl Med"},{"key":"2834_CR9","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1007\/s00259-020-04788-w","volume":"47","author":"L Beyer","year":"2020","unstructured":"Beyer L, Nitschmann A, Barthel H, van Eimeren T, Unterrainer M, Sauerbeck J et al (2020) Early-phase [(18)F]PI-2620 tau-PET imaging as a surrogate marker of neuronal injury. Eur J Nucl Med Mol Imaging 47:2911\u20132922. https:\/\/doi.org\/10.1007\/s00259-020-04788-w","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2834_CR10","doi-asserted-by":"publisher","first-page":"265930","DOI":"10.2967\/jnumed.123.265930","volume":"123","author":"GN Bischof","year":"2024","unstructured":"Bischof GN, Brendel M, Barthel H, Theis H, Barbe M, Bartenstein P et al (2024) Improved Tau PET SUVR quantification in 4-repeat tau phenotypes with [18F]PI-2620. J Nuclear Med 123:265930. https:\/\/doi.org\/10.2967\/jnumed.123.265930","journal-title":"J Nuclear Med"},{"key":"2834_CR11","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.2967\/jnumed.123.265856","volume":"64","author":"G Blazhenets","year":"2023","unstructured":"Blazhenets G, Soleimani-Meigooni DN, Thomas W, Mundada N, Brendel M, Vento S et al (2023) [(18)F]PI-2620 binding patterns in patients with suspected alzheimer disease and frontotemporal lobar degeneration. J Nucl Med 64:1980\u20131989. https:\/\/doi.org\/10.2967\/jnumed.123.265856","journal-title":"J Nucl Med"},{"key":"2834_CR12","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1001\/jamaneurol.2020.2526","volume":"77","author":"M Brendel","year":"2020","unstructured":"Brendel M, Barthel H, van Eimeren T, Marek K, Beyer L, Song M et al (2020) Assessment of 18F-PI-2620 as a biomarker in progressive supranuclear palsy. JAMA Neurol 77:1408\u20131419. https:\/\/doi.org\/10.1001\/jamaneurol.2020.2526","journal-title":"JAMA Neurol"},{"key":"2834_CR13","doi-asserted-by":"publisher","first-page":"792","DOI":"10.2967\/jnumed.115.163493","volume":"57","author":"M Brendel","year":"2016","unstructured":"Brendel M, Jaworska A, Probst F, Overhoff F, Korzhova V, Lindner S et al (2016) Small-animal pet imaging of tau pathology with 18F-THK5117 in 2 transgenic mouse models. J Nucl Med 57:792\u2013798. https:\/\/doi.org\/10.2967\/jnumed.115.163493","journal-title":"J Nucl Med"},{"key":"2834_CR14","doi-asserted-by":"publisher","first-page":"9535","DOI":"10.1073\/pnas.1301175110","volume":"110","author":"F Clavaguera","year":"2013","unstructured":"Clavaguera F, Akatsu H, Fraser G, Crowther RA, Frank S, Hench J et al (2013) Brain homogenates from human tauopathies induce tau inclusions in mouse brain. Proc Natl Acad Sci USA 110:9535\u20139540. https:\/\/doi.org\/10.1073\/pnas.1301175110","journal-title":"Proc Natl Acad Sci USA"},{"key":"2834_CR15","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1093\/jnen\/nlac094","volume":"81","author":"DG Coughlin","year":"2022","unstructured":"Coughlin DG, Hiniker A, Peterson C, Kim Y, Arezoumandan S, Giannini L et al (2022) Digital histological study of neocortical grey and white matter tau burden across tauopathies. J Neuropathol Exp Neurol 81:953\u2013964. https:\/\/doi.org\/10.1093\/jnen\/nlac094","journal-title":"J Neuropathol Exp Neurol"},{"key":"2834_CR16","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/j.1750-3639.2007.00054.x","volume":"17","author":"DW Dickson","year":"2007","unstructured":"Dickson DW, Rademakers R, Hutton ML (2007) Progressive supranuclear palsy: pathology and genetics. Brain Pathol 17:74\u201382. https:\/\/doi.org\/10.1111\/j.1750-3639.2007.00054.x","journal-title":"Brain Pathol"},{"key":"2834_CR17","doi-asserted-by":"publisher","first-page":"3508","DOI":"10.1093\/cercor\/bhw157","volume":"26","author":"L Fan","year":"2016","unstructured":"Fan L, Li H, Zhuo J, Zhang Y, Wang J, Chen L et al (2016) The human brainnetome atlas: a new brain atlas based on connectional architecture. Cereb Cortex 26:3508\u20133526. https:\/\/doi.org\/10.1093\/cercor\/bhw157","journal-title":"Cereb Cortex"},{"key":"2834_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-023-02188-8","author":"A Finze","year":"2023","unstructured":"Finze A, Biechele G, Rauchmann BS, Franzmeier N, Palleis C, Katzdobler S et al (2023) Individual regional associations between Abeta-, tau- and neurodegeneration (ATN) with microglial activation in patients with primary and secondary tauopathies. Mol Psychiatry. https:\/\/doi.org\/10.1038\/s41380-023-02188-8","journal-title":"Mol Psychiatry"},{"key":"2834_CR19","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1038\/s41467-022-28896-3","volume":"13","author":"N Franzmeier","year":"2022","unstructured":"Franzmeier N, Brendel M, Beyer L, Slemann L, Kovacs GG, Arzberger T et al (2022) Tau deposition patterns are associated with functional connectivity in primary tauopathies. Nat Commun 13:1362. https:\/\/doi.org\/10.1038\/s41467-022-28896-3","journal-title":"Nat Commun"},{"key":"2834_CR20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12974-023-02735-8","volume":"20","author":"J Gnorich","year":"2023","unstructured":"Gnorich J, Reifschneider A, Wind K, Zatcepin A, Kunte ST, Beumers P et al (2023) Depletion and activation of microglia impact metabolic connectivity of the mouse brain. J Neuroinflammation 20:47. https:\/\/doi.org\/10.1186\/s12974-023-02735-8","journal-title":"J Neuroinflammation"},{"key":"2834_CR21","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/hbm.10123","volume":"19","author":"A Hammers","year":"2003","unstructured":"Hammers A, Allom R, Koepp MJ, Free SL, Myers R, Lemieux L (2003) Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe. Hum Brain Mapp 19:224\u2013247. https:\/\/doi.org\/10.1002\/hbm.10123","journal-title":"Hum Brain Mapp"},{"key":"2834_CR22","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1002\/glia.22683","volume":"62","author":"S Herculano-Houzel","year":"2014","unstructured":"Herculano-Houzel S (2014) The glia\/neuron ratio: how it varies uniformly across brain structures and species and what that means for brain physiology and evolution. Glia 62:1377\u20131391. https:\/\/doi.org\/10.1002\/glia.22683","journal-title":"Glia"},{"key":"2834_CR23","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mds.26987","volume":"32","author":"GU H\u00f6glinger","year":"2017","unstructured":"H\u00f6glinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE et al (2017) Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord 32:853\u2013864. https:\/\/doi.org\/10.1002\/mds.26987","journal-title":"Mov Disord"},{"key":"2834_CR24","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00259-022-05964-w","volume":"50","author":"S Katzdobler","year":"2023","unstructured":"Katzdobler S, Nitschmann A, Barthel H, Bischof G, Beyer L, Marek K et al (2023) Additive value of [(18)F]PI-2620 perfusion imaging in progressive supranuclear palsy and corticobasal syndrome. Eur J Nucl Med Mol Imaging 50:423\u2013434. https:\/\/doi.org\/10.1007\/s00259-022-05964-w","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2834_CR25","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1007\/s00429-016-1352-4","volume":"222","author":"MC Keuken","year":"2017","unstructured":"Keuken MC, Bazin PL, Backhouse K, Beekhuizen S, Himmer L, Kandola A et al (2017) Effects of aging on T\u2081, T\u2082*, and QSM MRI values in the subcortex. Brain Struct Funct 222:2487\u20132505. https:\/\/doi.org\/10.1007\/s00429-016-1352-4","journal-title":"Brain Struct Funct"},{"key":"2834_CR26","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s11307-022-01779-1","volume":"25","author":"AC Knight","year":"2023","unstructured":"Knight AC, Morrone CD, Varlow C, Yu WH, McQuade P, Vasdev N (2023) Head-to-head comparison of tau-PET radioligands for imaging TDP-43 in post-mortem ALS brain. Mol Imaging Biol 25:513\u2013527. https:\/\/doi.org\/10.1007\/s11307-022-01779-1","journal-title":"Mol Imaging Biol"},{"key":"2834_CR27","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1007\/s00259-019-04397-2","volume":"46","author":"H Kroth","year":"2019","unstructured":"Kroth H, Oden F, Molette J, Schieferstein H, Capotosti F, Mueller A et al (2019) Discovery and preclinical characterization of [(18)F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer\u2019s disease and other tauopathies. Eur J Nucl Med Mol Imaging 46:2178\u20132189. https:\/\/doi.org\/10.1007\/s00259-019-04397-2","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2834_CR28","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1021\/acschemneuro.2c00291","volume":"13","author":"G K\u00fcnze","year":"2022","unstructured":"K\u00fcnze G, K\u00fcmpfel R, Rullmann M, Barthel H, Brendel M, Patt M et al (2022) Molecular simulations reveal distinct energetic and kinetic binding properties of [(18)F]PI-2620 on Tau filaments from 3R\/4R and 4R tauopathies. ACS Chem Neurosci 13:2222\u20132234. https:\/\/doi.org\/10.1021\/acschemneuro.2c00291","journal-title":"ACS Chem Neurosci"},{"key":"2834_CR29","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.dadm.2018.01.007","volume":"10","author":"L Lemoine","year":"2018","unstructured":"Lemoine L, Leuzy A, Chiotis K, Rodriguez-Vieitez E, Nordberg A (2018) Tau positron emission tomography imaging in tauopathies: The added hurdle of off-target binding. Alzheimer\u2019s & Dementia: Diagn Assess Dis Monitor 10:232\u2013236. https:\/\/doi.org\/10.1016\/j.dadm.2018.01.007","journal-title":"Alzheimer's & Dementia: Diagn Assess Dis Monitor"},{"key":"2834_CR30","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/jcbfm.1990.127","volume":"10","author":"J Logan","year":"1990","unstructured":"Logan J, Fowler JS, Volkow ND, Wolf AP, Dewey SL, Schlyer DJ et al (1990) Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab 10:740\u2013747. https:\/\/doi.org\/10.1038\/jcbfm.1990.127","journal-title":"J Cereb Blood Flow Metab"},{"key":"2834_CR31","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40478-016-0315-6","volume":"4","author":"VJ Lowe","year":"2016","unstructured":"Lowe VJ, Curran G, Fang P, Liesinger AM, Josephs KA, Parisi JE et al (2016) An autoradiographic evaluation of AV-1451 Tau PET in dementia. Acta Neuropathol Commun 4:58. https:\/\/doi.org\/10.1186\/s40478-016-0315-6","journal-title":"Acta Neuropathol Commun"},{"key":"2834_CR32","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1038\/s41380-022-01875-2","volume":"28","author":"M-L Malarte","year":"2023","unstructured":"Malarte M-L, Gillberg P-G, Kumar A, Bogdanovic N, Lemoine L, Nordberg A (2023) Discriminative binding of tau PET tracers PI2620, MK6240 and RO948 in Alzheimer\u2019s disease, corticobasal degeneration and progressive supranuclear palsy brains. Mol Psychiatry 28:1272\u20131283. https:\/\/doi.org\/10.1038\/s41380-022-01875-2","journal-title":"Mol Psychiatry"},{"key":"2834_CR33","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1002\/ana.24517","volume":"78","author":"M Marquie","year":"2015","unstructured":"Marquie M, Normandin MD, Vanderburg CR, Costantino IM, Bien EA, Rycyna LG et al (2015) Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue. Ann Neurol 78:787\u2013800. https:\/\/doi.org\/10.1002\/ana.24517","journal-title":"Ann Neurol"},{"key":"2834_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1162\/imag_a_00135","volume":"2","author":"A McVea","year":"2024","unstructured":"McVea A, DiFilippo A, McLachlan MJ, Zammit MD, Bendlin B, Johnson SC (2024) Evaluating the effect of extra-cerebral off-target binding in [F-18]MK6240 PET scans in early-stage Alzheimer\u2019s disease. Imaging Neurosci 2:1\u201320. https:\/\/doi.org\/10.1162\/imag_a_00135","journal-title":"Imaging Neurosci"},{"key":"2834_CR35","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/syn.21558","volume":"66","author":"E Mille","year":"2012","unstructured":"Mille E, Cumming P, Rominger A, La Foug\u00e8re C, Tatsch K, W\u00e4ngler B et al (2012) Compensation for cranial spill-in into the cerebellum improves quantitation of striatal dopamine D2\/3 receptors in rats with prolonged [18F]-DMFP infusions. Synapse 66:705\u2013713. https:\/\/doi.org\/10.1002\/syn.21558","journal-title":"Synapse"},{"key":"2834_CR36","doi-asserted-by":"publisher","first-page":"11406","DOI":"10.1523\/jneurosci.1230-17.2017","volume":"37","author":"S Narasimhan","year":"2017","unstructured":"Narasimhan S, Guo JL, Changolkar L, Stieber A, McBride JD, Silva LV et al (2017) Pathological tau strains from human brains recapitulate the diversity of tauopathies in nontransgenic mouse brain. J Neurosci: Off J Soc Neurosci 37:11406\u201311423. https:\/\/doi.org\/10.1523\/jneurosci.1230-17.2017","journal-title":"J Neurosci: Off J Soc Neurosci"},{"key":"2834_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2019.102091","volume":"24","author":"KP Ng","year":"2019","unstructured":"Ng KP, Therriault J, Kang MS, Struyfs H, Pascoal TA, Mathotaarachchi S et al (2019) Rasagiline, a monoamine oxidase B inhibitor, reduces in vivo [(18)F]THK5351 uptake in progressive supranuclear palsy. Neuroimage Clin 24:102091. https:\/\/doi.org\/10.1016\/j.nicl.2019.102091","journal-title":"Neuroimage Clin"},{"key":"2834_CR38","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3389\/fnins.2016.00045","volume":"10","author":"F Overhoff","year":"2016","unstructured":"Overhoff F, Brendel M, Jaworska A, Korzhova V, Delker A, Probst F et al (2016) Automated spatial brain normalization and hindbrain white matter reference tissue give improved [(18)F]-florbetaben PET quantitation in Alzheimer\u2019s model mice. Front Neurosci 10:45. https:\/\/doi.org\/10.3389\/fnins.2016.00045","journal-title":"Front Neurosci"},{"key":"2834_CR39","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1002\/mds.28624","volume":"36","author":"C Palleis","year":"2021","unstructured":"Palleis C, Brendel M, Finze A, Weidinger E, Botzel K, Danek A et al (2021) Cortical [(18) F]PI-2620 binding differentiates corticobasal syndrome subtypes. Mov Disord 36:2104\u20132115. https:\/\/doi.org\/10.1002\/mds.28624","journal-title":"Mov Disord"},{"key":"2834_CR40","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s40478-023-01674-y","volume":"11","author":"T Pansuwan","year":"2023","unstructured":"Pansuwan T, Quaegebeur A, Kaalund SS, Hidari E, Briggs M, Rowe JB et al (2023) Accurate digital quantification of tau pathology in progressive supranuclear palsy. Acta Neuropathol Commun 11:178. https:\/\/doi.org\/10.1186\/s40478-023-01674-y","journal-title":"Acta Neuropathol Commun"},{"key":"2834_CR41","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.neurobiolaging.2021.09.006","volume":"109","author":"H Patel","year":"2022","unstructured":"Patel H, Martinez P, Perkins A, Taylor X, Jury N, McKinzie D et al (2022) Pathological tau and reactive astrogliosis are associated with distinct functional deficits in a mouse model of tauopathy. Neurobiol Aging 109:52\u201363. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2021.09.006","journal-title":"Neurobiol Aging"},{"key":"2834_CR42","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/mds.27872","volume":"35","author":"G Respondek","year":"2020","unstructured":"Respondek G, Grimm MJ, Piot I, Arzberger T, Compta Y, Englund E et al (2020) Validation of the movement disorder society criteria for the diagnosis of 4-repeat tauopathies. Mov Disord 35:171\u2013176. https:\/\/doi.org\/10.1002\/mds.27872","journal-title":"Mov Disord"},{"key":"2834_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22116132","author":"A Robert","year":"2021","unstructured":"Robert A, Sch\u00f6ll M, Vogels T (2021) Tau seeding mouse models with patient brain-derived aggregates. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22116132","journal-title":"Int J Mol Sci"},{"key":"2834_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2019.101644","volume":"180","author":"TW R\u00f6sler","year":"2019","unstructured":"R\u00f6sler TW, Tayaranian Marvian A, Brendel M, Nyk\u00e4nen NP, H\u00f6llerhage M, Schwarz SC et al (2019) Four-repeat tauopathies. Prog Neurobiol 180:101644. https:\/\/doi.org\/10.1016\/j.pneurobio.2019.101644","journal-title":"Prog Neurobiol"},{"key":"2834_CR45","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1177\/0271678X211018904","volume":"41","author":"M Song","year":"2021","unstructured":"Song M, Beyer L, Kaiser L, Barthel H, van Eimeren T, Marek K et al (2021) Binding characteristics of [(18)F]PI-2620 distinguish the clinically predicted tau isoform in different tauopathies by PET. J Cereb Blood Flow Metab 41:2957\u20132972. https:\/\/doi.org\/10.1177\/0271678X211018904","journal-title":"J Cereb Blood Flow Metab"},{"key":"2834_CR46","doi-asserted-by":"publisher","first-page":"3872","DOI":"10.1007\/s00259-021-05391-3","volume":"48","author":"M Song","year":"2021","unstructured":"Song M, Scheifele M, Barthel H, van Eimeren T, Beyer L, Marek K et al (2021) Feasibility of short imaging protocols for [(18)F]PI-2620 tau-PET in progressive supranuclear palsy. Eur J Nucl Med Mol Imaging 48:3872\u20133885. https:\/\/doi.org\/10.1007\/s00259-021-05391-3","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2834_CR47","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-021-05391-3","author":"M Song","year":"2021","unstructured":"Song M, Scheifele M, Barthel H, van Eimeren T, Beyer L, Marek K et al (2021) Feasibility of short imaging protocols for [(18)F]PI-2620 tau-PET in progressive supranuclear palsy. Eur J Nucl Med Mol Imaging. https:\/\/doi.org\/10.1007\/s00259-021-05391-3","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2834_CR48","first-page":"333","volume":"10","author":"JC Steele","year":"1964","unstructured":"Steele JC, Richardson JC, Olszewski J (1964) Progressive supranuclear palsy. a heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy. Nuchal Dystonia Dementia Arch Neurol 10:333\u2013359","journal-title":"Nuchal Dystonia Dementia Arch Neurol"},{"key":"2834_CR49","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.neuron.2020.09.042","volume":"109","author":"K Tagai","year":"2021","unstructured":"Tagai K, Ono M, Kubota M, Kitamura S, Takahata K, Seki C et al (2021) High-Contrast in vivo imaging of tau pathologies in Alzheimer\u2019s and non-Alzheimer\u2019s disease tauopathies. Neuron 109:42-58.e48. https:\/\/doi.org\/10.1016\/j.neuron.2020.09.042","journal-title":"Neuron"},{"key":"2834_CR50","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.neurobiolaging.2022.06.014","volume":"124","author":"AM Tetlow","year":"2023","unstructured":"Tetlow AM, Jackman BM, Alhadidy MM, Muskus P, Morgan DG, Gordon MN (2023) Neural atrophy produced by AAV tau injections into hippocampus and anterior cortex of middle-aged mice. Neurobiol Aging 124:39\u201350. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2022.06.014","journal-title":"Neurobiol Aging"},{"key":"2834_CR51","doi-asserted-by":"publisher","first-page":"fcab190","DOI":"10.1093\/braincomms\/fcab190","volume":"3","author":"T Tezuka","year":"2021","unstructured":"Tezuka T, Takahata K, Seki M, Tabuchi H, Momota Y, Shiraiwa M et al (2021) Evaluation of [(18)F]PI-2620, a second-generation selective tau tracer, for assessing four-repeat tauopathies. Brain Commun 3:fcab190. https:\/\/doi.org\/10.1093\/braincomms\/fcab190","journal-title":"Brain Commun"},{"key":"2834_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.nucmedbio.2024.108891","volume":"130\u2013131","author":"C Varlow","year":"2024","unstructured":"Varlow C, Mathis CA, Vasdev N (2024) In vitro evaluation of [3H]PI-2620 and structural derivatives in non-Alzheimer\u2019s tauopathies. Nucl Med Biol 130\u2013131:108891. https:\/\/doi.org\/10.1016\/j.nucmedbio.2024.108891","journal-title":"Nucl Med Biol"},{"key":"2834_CR53","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1007\/s00259-022-06087-y","volume":"50","author":"F Volter","year":"2023","unstructured":"Volter F, Beyer L, Eckenweber F, Scheifele M, Bui N, Patt M et al (2023) Assessment of perfusion deficit with early phases of [(18)F]PI-2620 tau-PET versus [(18)F]flutemetamol-amyloid-PET recordings. Eur J Nucl Med Mol Imaging 50:1384\u20131394. https:\/\/doi.org\/10.1007\/s00259-022-06087-y","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2834_CR54","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nrn.2015.1","volume":"17","author":"Y Wang","year":"2016","unstructured":"Wang Y, Mandelkow E (2016) Tau in physiology and pathology. Nat Rev Neurosci 17:22\u201335. https:\/\/doi.org\/10.1038\/nrn.2015.1","journal-title":"Nat Rev Neurosci"},{"key":"2834_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.684523","volume":"12","author":"M Willroider","year":"2021","unstructured":"Willroider M, Roeber S, Horn AKE, Arzberger T, Scheifele M, Respondek G et al (2021) Superiority of formalin-fixed paraffin-embedded brain tissue for in vitro assessment of progressive supranuclear palsy tau pathology with [(18) F]PI-2620. Front Neurol 12:684523. https:\/\/doi.org\/10.3389\/fneur.2021.684523","journal-title":"Front Neurol"},{"key":"2834_CR56","doi-asserted-by":"publisher","first-page":"eabe5640","DOI":"10.1126\/scitranslmed.abe5640","volume":"13","author":"X Xiang","year":"2021","unstructured":"Xiang X, Wind K, Wiedemann T, Blume T, Shi Y, Briel N et al (2021) Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases. Sci Transl Med 13:eabe5640. https:\/\/doi.org\/10.1126\/scitranslmed.abe5640","journal-title":"Sci Transl Med"},{"key":"2834_CR57","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","volume":"53","author":"Y Yoshiyama","year":"2007","unstructured":"Yoshiyama Y, Higuchi M, Zhang B, Huang SM, Iwata N, Saido TC et al (2007) Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 53:337\u2013351. https:\/\/doi.org\/10.1016\/j.neuron.2007.01.010","journal-title":"Neuron"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-024-02834-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00401-024-02834-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-024-02834-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T09:02:21Z","timestamp":1732438941000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00401-024-02834-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,24]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2834"],"URL":"https:\/\/doi.org\/10.1007\/s00401-024-02834-7","relation":{},"ISSN":["1432-0533"],"issn-type":[{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,24]]},"assertion":[{"value":"14 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MB is a member of the Neuroimaging Committee of the EANM. MB has received speaker honoraria from Roche, GE Healthcare, and Life Molecular Imaging; has advised Life Molecular Imaging; and is currently on the advisory board of MIAC. NF received speaker honoraria from Eisai and Life Molecular Imaging and consulting honoraria from MSD. CP and JL are inventors in the patent \u201cOral Phenylbutyrate for Treatment of Human 4-Repeat Tauopathies\u201d (EP 23 156 122.6) filed by LMU Munich. JL reports speaker fees from Bayer Vital, Biogen and Roche; consulting fees from Axon Neuroscience and Biogen; author fees from Thieme Medical Publishers and W. Kohlhammer GmbH Medical Publishers; nonfinancial support from AbbVie; and compensation for duty as part-time CMO from MODAG, all outside the submitted work. TvE reports speaker\/consultant fees from Eli Lilly, Shire, H. Lundbeck A\/S, and Orion Corporation, and author fees from Thieme Medical Publishers, all without conflicts of interest with regard to the submitted work. Gesine Respondek has been a full-time employee at Roche Pharmaceuticals since July 2021 and has consulted for UCB, all outside of the submitted work. AZ reports speaker fees and research support from Dr. Willmar Schwabe GmbH and author fees from Thieme Medical Publishers, Springer Medical Publishers and W. Kohlhammer GmbH Medical Publishers. In addition to the submitted work, TG received consulting fees from AbbVie, Alector, Anavex, Biogen, BMS, Cogthera, Eli Lilly, Functional Neuromodulation, Grifols, Iqvia, Janssen, Noselab, Novo Nordisk, NuiCare, Orphanzyme, Roche Diagnostics, Roche Pharma, UCB, and Vivoryon; lecture fees from Biogen, Eisai, Grifols, Medical Tribune, Novo Nordisk, Roche Pharma, Schwabe, and Synlab; and grants to his institution from Biogen, Eisai, and Roche Diagnostics. LB is a Novartis Pharma GmbH employee, unrelated to this work. All the other authors declare that no conflicts of interest exist.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"70"}}